EXPONENT INC quarterly report, Q1 FY2024

Business context and reporting period

Exponent, Inc. is an engineering and scientific consulting firm. The supplied filing is a Form 10-Q for the three months ended March 29, 2024, compared with the three months ended March 31, 2023. This conflicts with the request metadata of “2023 Q1”; the filing itself reports first-quarter 2024.

Financial and operating highlights

MetricQ1 2024Q1 2023Change
Revenue$144.9 million$140.3 million+3.3%
Revenue before reimbursements$137.2 million$128.7 million+6.6%
Operating income$30.7 million$29.1 million+5.5%
Net income$30.1 million$29.1 million+3.5%
Diluted EPS$0.59$0.56Higher
Operating cash flow$10.4 million$(6.7) millionImproved

Operating margin was approximately 21.2% of revenue, versus 20.8% a year earlier. EBITDA was $40.1 million, or 29.2% of revenue before reimbursements, compared with $35.8 million, or 27.8%. The effective tax rate rose to 25.4% from 18.0%; excluding excess stock-award tax benefits, management reported rates of 27.8% and 28.3%, respectively.

Engineering and Other Scientific revenue increased 3.8% to $121.5 million; Environmental and Health revenue increased 0.9% to $23.5 million. Billable hours rose 2% to 392,000 and utilization increased to 75% from 70%. Technical full-time-equivalent employees declined 5% to 1,003.

Liquidity, capital and balance sheet

Cash and cash equivalents were $168.7 million at March 29, 2024, down from $187.2 million at December 29, 2023. Current assets were $352.3 million and current liabilities $114.1 million. The filing reports no borrowings or debt; operating lease liabilities totaled $27.2 million. Net cash used in investing was $1.5 million, primarily capital expenditures. Financing used $27.2 million, including dividends, share repurchases and payroll taxes on restricted stock units.

Quarterly dividends declared were $0.28 per share, versus $0.26 a year earlier. The company repurchased 71,000 shares for approximately $5.5 million. Management said available cash, cash equivalents, short-term investments and operating cash generation should cover requirements for at least the next 12 months.

Material changes, outlook and risks

  • Management attributed growth mainly to reactive failure-analysis and dispute work, with strength in energy, vehicle and medical-device sectors. Proactive work excluding consumer electronics also grew; consumer electronics remained cyclically weak.
  • Compensation expense increased 7.3%, and other operating expenses increased 10.1%. Higher compensation reflected payroll, benefits, bonuses and deferred-compensation plan movements. Gains on plan assets are substantially offset by related compensation expense.
  • Management expected a small sequential decline in average technical headcount in Q2, followed by sequential growth in the second half of 2024. It expects compensation and operating expenses to rise as it selectively hires and invests. No specific revenue or earnings guidance was provided.
  • The company expected to finalize a 15-year extension of its Arizona land lease in Q2; as of the filing date, it was not executed. Management expected annual rent of $6.2 million beginning in 2028 and described additional non-cash rent expense during 2024.
  • Management identified demand and engagement timing, competition and pricing, talent retention, regulation and claims as risks. It reported no material legal proceedings and no material changes to previously disclosed risk factors. Foreign-exchange exposure may grow with international operations; the company does not hedge currency exposure.

Important facts for investors to verify

  • Confirm the intended reporting period: the filing is Q1 2024, not Q1 2023.
  • Assess whether growth in core revenue and utilization can continue amid lower headcount and weakness in consumer electronics.
  • Monitor cash conversion and working-capital movements, including annual bonus payments and deferred revenue.
  • Review the Arizona lease extension’s final terms and execution status, and the resulting rent expense and cash commitments.
  • Distinguish deferred-compensation investment gains from underlying operating performance; the filing reports corresponding compensation expense.